Establishment of a new ELN solution! Efficiently and in real-time, collect, accumulate, and share information.
In 2005, Sepracor Inc. (now Sanofi-Aventis) conducted its first evaluation of ELN systems. The company transitioned drug discovery from in-house teams to CROs, effectively shifting most of its research to Europe and Asia. However, due to the geographical distance from these laboratories, obtaining data became challenging. After six months of evaluating about 20 ELN solutions, they ultimately chose "Arxspan Notebook" (electronic lab notebook) that met the company's needs. The ability to enhance real-time evaluation and communication led to significant time savings and improvements in the quality of scientific activities overall. [Challenges] - Obtaining data became difficult due to the geographical distance from the laboratories. - The system for collecting, storing, and searching various types of data became cumbersome and inefficient. *For more details, please refer to the PDF document or feel free to contact us.*
Inquire About This Product
basic information
【Results】 ■ Improvement in labor productivity ■ Enhanced access to both ongoing and historical data ■ Significant improvement in communication and time efficiency *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs![[Example] Introduce a cloud-based electronic lab notebook to efficiently and in real-time collect, store, and share information.](https://image.mono.ipros.com/public/catalog/image/01/d40/681779/IPROS98899467326108130674.jpeg?w=120&h=170)
Company information
Bruker Biospin Group designs, manufactures, and sells instruments based on magnetic resonance technology, including world-class nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectrometers. They also develop preclinical imaging systems with single and multiple modes using magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), computed tomography (CT), and magnetic particle imaging (MPI) technologies. Bruker Biospin provides the unique capabilities of NMR to determine the structure, dynamics, and functions of specific molecules to customers in academic research institutions, government agencies, industry, and pharmaceutical companies. In particular, applications in structural proteomics, drug discovery, pharmaceutical and biotechnology research and production, and food and materials science are expected to be promising.